ORF18-05 - A Novel TSHR Blocking Antibody Effectively Reduces Hyperthyroidism and Proptosis in a Mouse Model of Graves' and Thyroid Eye Disease

Oral Abstract Presenter(s)

• MA

  Mutayyaba Adnan, MPH

  Scientist
  REGENERON PHARM INC
  Tarrytown, NY, United States

Co-Author(s)

• SM

  Santiago Mendez-Huergo, PhD

  Regeneron Pharmaceuticals, Inc.
  Tarrytown, United States
• MP

  Marilena Preda, MSRIS

  Regeneron Pharmaceuticals, Inc.
  Tarrytown, United States
• LS

  Leigh Spencer Noakes, PhD

  Regeneron Pharmaceuticals, Inc.
  Tarrytown, United States
• MM

  Matthew Marzelli, MS

  Regeneron Pharmaceuticals, Inc.
  Tarrytown, United States
• GG

  Gustavo Gimenez, MS

  Regeneron Pharmaceuticals, Inc.
  Tarrytown, United States
• AA

  Anass Agrud, n/a

  Regeneron Pharmaceuticals, Inc.
  Tarrytown, United States
• MG

  Mary Germino, PhD

  Regeneron Pharmaceuticals, Inc.
  Tarrytown, United States
• JW

  Johnathon Walls, PhD

  Regeneron Pharmaceuticals, Inc.
  Tarrytown, United States
• GL

  Guillermo Lehmann, MD, PhD

  Regeneron Pharmaceuticals, Inc.
  Tarrytown, United States
• 

  Bristol Denlinger, Ph.D.

  REGENERON PHARM INC
  Tarrytown, NY, United States

Senior Author/Primary Investigator(s)

• BS

  Botir Sagdullaev, PhD

  Regeneron Pharmaceuticals, Inc.
  Tarrytown, United States